Luteinizing hormone release after administration of the gonadotropin-releasing hormone agonist Fertilan (goserelin) for synchronization of ovulation in pigs

• Published in: Journal of animal science Vol. 85; no. 1; pp. 129 - 137
• Main Authors: Brussow, K.-P, Schneider, F, Tuchscherer, A, Ratky, J, Kraeling, R. R, Kanitz, W
• Format: Journal Article
• Language: English
• Published: Savoy, IL Am Soc Animal Sci 01.01.2007; American Society of Animal Science; Oxford University Press
• Subjects: Animal productions; Animals; Biological and medical sciences; Chorionic Gonadotropin - pharmacology; Endocrinology; Estrus Synchronization - drug effects; Female; Fertility; Fundamental and applied biological sciences. Psychology; Gonadotropin-Releasing Hormone - agonists; Goserelin - pharmacology; Hogs; Hormones; Luteinizing Hormone - blood; Luteinizing Hormone - metabolism; Male; Ovulation Induction - veterinary; Reproductive system; Swine; Terrestrial animal productions; Trenbolone Acetate - analogs & derivatives; Trenbolone Acetate - pharmacology; Vertebrates; Zoology; Hormone; Agonist; Farming animal; Gonadotropin; Synchronization; Ovulation; Pig; Vertebrata; Meat animals; Mammalia; Luteinizing hormone; gonadotropin-releasing hormone agonist; Artiodactyla; Ungulata; Release
• ISSN: 0021-8812; 1525-3163
• DOI: 10.2527/jas.2006-281

The generic GnRH agonist, Fertilan (goserelin), was tested for the ability to induce an LH surge and ovulation in estrus-synchronized gilts. Three experiments were performed to 1) examine the effect of various doses of Fertilan on secretion of LH in barrows, to select doses to investigate in gilts (Exp. 1); 2) determine doses of Fertilan that would induce a preovulatory-like rise of LH in gilts (Exp. 2); and 3) determine the time of ovulation after Fertilan treatment (Exp. 3). In Exp. 1, 10 barrows were injected on d 1, 4, 7, 10, and 13 with 10, 20, or 40 microg of Fertilan; 50 microg of Gonavet (depherelin; GnRH control) or saline (negative control); and sequential blood samples were collected for 480 min. There was a dose-dependent stimulation (P < 0.05) of LH release. Maximal plasma concentrations of LH (LH(MAX)) were 2.1 +/- 0.2, 4.1 +/- 0.3, 2.6 +/- 0.4, and 3.4 +/- 0.3 ng/mL after 10, 20, and 40 microg of Fertilan and 50 microg of Gonavet, respectively, and duration of release was 78 +/- 9, 177 +/- 12, 138 +/- 7, and 180 +/- 11 min, respectively. Fertilan doses of 10 and 20 microg were deemed to be the most suitable for testing in gilts. In Exp. 2, 12 gilts received (after estrus synchronization with Regumate and eCG) injections of 10 or 20 microg of Fertilan or 50 microg of Gonavet 80 h after eCG to stimulate a preovulatory-like LH surge and ovulation. An LH surge was induced in 3 of the 4 gilts in both of the Fertilan groups and in all of the Gonavet-treated gilts. Characteristics of induced release of LH did not differ among groups: LH(MAX), 5.0 +/- 0.9 vs. 4.6 +/- 1.8 vs. 6.6 +/- 1.1 ng/mL; duration, 11.7 +/- 2.0 vs. 12.3 +/- 2.2 vs. 14.3 +/- 0.5 h; interval from GnRH injection to LH(MAX), 4.0 +/- 2.0 vs. 6.7 +/- 1.3 vs. 5.8 +/- 1.6 h. In Exp. 3, estrus-synchronized gilts were injected with 20 microg of Fertilan (n = 8) or 50 microg of Gonavet (n = 4), and the time of ovulation was determined by repeated endoscopic examination. Time of ovulation ranged from 34 to 42 h postGnRH; however, ovulation occurred earlier in the Gonavet compared with the other groups (P < 0.05). Results of these experiments indicate that 1) barrows are an appropriate model for determining GnRH doses that can be effective in inducing a preovulatory-like LH surge in females; 2) the generic GnRH agonist Fertilan, at doses of 10 to 20 microg, can stimulate an LH surge in gilts, with subsequent ovulation; and 3) Fertilan at doses of 10 and 20 microg should be examined further for use in fixed-time insemination protocols.